Single-agent pegylated liposomal doxorubicin (Caelix) in chemotherapy pretreated non-small cell lung cancer patients: a pilot trial. [electronic resource]
Producer: 20020531Description: 59-64 p. digitalISSN:- 0169-5002
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Doxorubicin -- administration & dosage
- Female
- Humans
- Infusions, Intravenous
- Liposomes
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Organoplatinum Compounds -- therapeutic use
- Pilot Projects
- Polyethylene Glycols
- Radiography, Thoracic
- Salvage Therapy
- Surface-Active Agents -- chemistry
- Tomography, X-Ray Computed
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.